41
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3560 |
Desmethylanethol trithione
ADT-OH |
VEGFR; Akt | Angiogenesis; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
Desmethylanethol trithione (ADT-OH) 是合成硫化氢的供体。它利用上调 FADD 诱导细胞凋亡,并对体内黑色素瘤的形成具有一定的抑制作用,可用于研究癌症疾病。 | |||
T60060 |
ACSS2-IN-2
MTB-9655 |
Fatty Acid Synthase | Metabolism |
ACSS2-IN-2 (MTB-9655) 是酰基辅酶 A 合成酶短链家族成员 2 (ACSS2) 抑制剂。ACSS2-IN-2 可抑制 ACSS2 活性,IC50 为 3.8 nM。ACSS2-IN-2 可用于多种疾病的研究,如病毒感染、代谢紊乱、神经精神疾病、炎症/自身免疫疾病和癌症。 | |||
T5337 |
IACS-010759
IACS-10759,IACS 10759,IACS10759 |
Apoptosis; Others; Mitochondrial Metabolism | Apoptosis; Metabolism; Others |
IACS-010759 是一种口服有效的线粒体氧化磷酸化复合物 I 抑制剂。它在依赖 OXPHOS 的脑癌和急性髓性白血病模型中抑制增殖并诱导细胞凋亡,有研究复发/难治性 AML 和实体瘤潜力。 | |||
T9196 |
IACS-13909
BBP-398 |
Phosphatase | Metabolism |
IACS-13909 (BBP-398) 是具有口服活性的、选择性的 SHP2变构抑制剂,其 IC50=15.7 nM,Kd=32 nM。与其他磷酸酶相比,它对 SHP2的选择性更高。它能够抑制受体酪氨酸激酶 (RTK)/MAPK 途径的信号传导,并具有抗癌作用。 | |||
T11595 | IACS-8779 | Others | Others |
IACS-8779 is a potent STING agonist that efficiently stimulates interferon gene activity and exhibits strong systemic antitumor effects. | |||
T62298 |
PHD2/HDACs-IN-1
|
||
PHD2/HDACs-IN-1 是一种有效的 PHD2/HDACs 混合抑制剂,能够作用于 PHD2 (IC50: 1.15 μM)、HDAC1 (IC50: 19.75 μM)、HDAC2 (IC50: 26.60 μM)、HDAC16 (IC50: 15.98 μM)。PHD2/HDACs-IN-1 是一种低毒性肾保护剂,能够用于顺铂诱导的急性肾损伤 (AKI) 的研究。 | |||
T11627 |
IACS-8968 R-enantiomer
IDO/TDO Inhibitor (R-enantiomer) |
IDO | Metabolism |
IACS-8968 R-enantiomer is the R-enantiomer of IACS-8968. IACS-8968 is a dual IDO and TDO inhibitor (pIC50s: 6.43 for IDO and <5 for TDO). | |||
T11596 |
IACS-8803
|
Others | Others |
IACS-8803 is a potent cyclic dinucleotide STING agonist that exhibits strong systemic antitumor efficacy. | |||
T69759 | IACS-9439 | c-Fms | Tyrosine Kinase/Adaptors |
IACS-9439是一种CSF1R抑制剂,具有高效、选择性和口服活性,Ki值仅为1 nM。适用于研究晚期实体肿瘤。 | |||
T72274 |
IACS-9571 hydrochloride
ASIS-P040 hydrochloride |
||
IACS-9571 (ASIS-P040) hydrochloride 是溴结构域蛋白 TRIM24和 BRPF1的抑制剂,对 TRIM24 的 IC50和 Kd 值分别为 8 nM 和 31 nM,对 BRPF1的 Kd 值为 14 nM。 | |||
T39999 |
IACS-15414
|
||
IACS-15414 is a potent SHP2 inhibitor that is effective when administered orally, demonstrating an IC50 value of 122 nM. | |||
T63397 |
ACSS2-IN-1
|
||
ACSS2-IN-1 是 ACSS2 的有效抑制剂,能够抑制 ACSS2 活性 ,其IC50值为 0.01 nM 到 <1 nM,能够用于研究癌症。 | |||
T70091 | IACS-4759 | ||
IACS-4759 is a novel potent and selective MTH1 inhibitor with excellent cell permeability and good metabolic stability in microsomes. | |||
T78566 | GlcNAcstatin | ||
GlcNAcstatin,一种基于葡萄糖咪唑的选择性细菌O-GlcNAcase抑制剂,其Ki值为4.6 pM,对HexA/B的选择性高出100000倍。 | |||
T27568 |
IACS-010759 hydrochloride
IACS-010759 HCl,IACS-010759,IACS10759,IACS-10759,IACS 10759 |
||
IACS-010759 is a potent inhibitor of complex I of OXPHOS with orally bioavailable. IACS-10759 effectively inhibits ATP production and oxygen consumption in isolated mitochondria, and inhibits the conversion of NADH to NAD+ in immunoprecipitated complex I | |||
T73939 | IACS-8803 diammonium | ||
IACS-8803 diammonium 是一种高效环状二核苷酸的STING 激动剂,具有强大的全身抗肿瘤作用。 | |||
T73938 |
IACS-8803 disodium
|
||
IACS-8803 disodium 是一种高效环状二核苷酸的STING 激动剂,具有强大的全身抗肿瘤作用。 | |||
T22551 | ACSF | Others | Others |
ACSF is often used as a replacement of CSF for perfusion of brain slices to preserve interneurons. ACSF is invented to reduce the incidence of cerebral edema and further suppress brain cell disorders. And ACSF is often used as an irrigation fluid or perfu | |||
T79303 |
IACS-52825
|
||
IACS-52825是一种选择性DLK抑制剂,具有1.3 nM的Kd值,适用于研究化疗引起的周围神经病变。 | |||
T27289 |
Etacstil
GW 5638,GW-5638,GW5638,DPC974,DPC 974,DPC-974 |
||
GW5638 is a estrogen receptor ligand. GW5638 is a prodrug of its active metabolite GW7604. GW5638 appears to act as an antagonist in these in vitro systems, although in a manner distinct from other known ER modulators. GW5638 is also classified as a pseud | |||
T11597L |
IACS-9571 Hydrochloride (1800477-30-8 free base)
IACS-9571 Hydrochloride,ASIS-P040 Hydrochloride |
Epigenetic Reader Domain | Chromatin/Epigenetic |
IACS-9571 Hydrochloride is a selective and potent inhibitor of TRIM24 and BRPF1, (IC50: 8 nM for TRIM24; Kds: 31 nM and 14 nM for TRIM24 and BRPF1). | |||
T11597 |
IACS-9571
ASIS-P040 |
Epigenetic Reader Domain | Chromatin/Epigenetic |
IACS-9571 is a selective and potent inhibitor of TRIM24 and BRPF1, (IC50: 8 nM for TRIM24; Kds: 31 nM and 14 nM for TRIM24 and BRPF1). | |||
T11544 | HDACs/mTOR Inhibitor 1 | HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
HDACs/mTOR Inhibitor 1 is a dual HDACs and mammalian target of Rapamycin (mTOR) target inhibitor for treating hematologic malignancies (IC50s: 0.19 nM, 1.8 nM, 1.2 nM, and >500 nM for HDAC1, HDAC6, mTOR and PI3Kα). | |||
T72516 |
IACS-8779 disodium
|
||
IACS-8779 disodium 是一种高效的干扰素基因刺激蛋白 (STING) 激动剂,具有强大的全身性抗肿瘤功效。IACS-8779 disodium 在 B16 小鼠黑色素瘤模型中对STING 通路具有强烈活性,且具有卓越的抗肿瘤作用。 | |||
T11628 |
IACS-8968 S-enantiomer
IDO/TDO Inhibitor (S-enantiomer) |
IDO | Metabolism |
IACS-8968 S-enantiomer is the S-enantiomer of IACS-8968. IACS-8968 is a dual IDO and TDO inhibitor (pIC50s: 6.43 for IDO and <5 for TDO). | |||
T11626 |
IACS-8968
IDO/TDO Inhibitor |
IDO | Metabolism |
IACS-8968 is a dual IDO and TDO inhibitor (pIC50s: 6.43 for IDO and <5 for TDO). | |||
T68088 |
Iodofiltic acid
|
||
Iodofiltic acid 可用于辅助治疗急性冠脉综合征(Zeus-ACS),可成像以检测心肌缺血。 | |||
T21059 |
Ticagrelor metabolite M5
Ticagrelor metabolite M5,,T437700,替格瑞洛杂质H,AR-C133913XX |
P2Y Receptor | GPCR/G Protein; Neuroscience |
Ticagrelor metabolite M5 (T437700) 是 Ticagrelor 的代谢物,是 P2Y12 受体的第一个可逆口服拮抗剂。与氯吡格雷相比,替格瑞洛对 ADP 受体具有更快和更一致的抑制作用。替格瑞洛用于治疗急性冠状动脉综合征(ACS)。 | |||
T76124 | Acyl coenzyme A synthetase | ||
Acyl coenzyme A synthetase (ACS),一种生化研究中常用的酶,主要通过两步硫酯化反应激活脂肪酸与辅酶A结合,形成酰基辅酶A。该过程为脂质代谢中的多种合成与分解代谢途径,以及参与TCA循环中的有氧呼吸提供了关键中间物。 | |||
T35674 | StRIP16 | ||
Rab8a GTPase-binding stapled peptide (Kd = 12.7 μM). Cell permeable; localizes to the endomembrane system. Cromm et al (2016) Protease-resistant and cell-permeable double-stapled peptides targeting the Rab8a GTPase. ACS Chem.Biol. 11 2375 PMID:27336832 | |||
T36016 | PF 06260933 dihydrochloride | ||
MAP4K4 (HGK) inhibitor (IC50 = 140 nM). Also inhibits MINK and TNIK (IC50 values are 8 and 13 nM, respectively). Improves fasting hyperglycemia in mice. Orally active. Ammirati et al (2015) Discovery of an in vivo tool to establish proof-of-concept for MAP4K4-based antidiabetic treatment. ACS Med.Chem.Lett. 6 1128 PMID:26617966 | |||
T36782 |
TAK1-IN-2
TAK1-IN-2 |
||
TAK1-IN-2 is a potent and selective TAK1 inhibitor, with an IC50> of 2 nM[1]. TAK1-IN-2 (compound 54) (10 μM) has no effect on cell viability in TNF-α stimulated HCT-15 cells[1]. [1]. Veerman JJN, et, al. Discovery of 2,4-1 H-Imidazole Carboxamides as Potent and Selective TAK1 Inhibitors. ACS Med Chem Lett. 2021 Mar 3;12(4):555-562. | |||
T36946 |
PW0464
PW0464 |
||
PW0464, a nanomolar potent complete G protein biased ligand, is a noncatechol D1R agonist, with an EC50 of 5.8 nM (Gs-cAMP)[1]. PW0464 (compound 24) is found to elicit complete G protein bias, showing no activity for D1R-mediated β-arrestin recruitment[1].PW0464 (compound 24), the non-catechol agonist, forms bonds with S1985.42 and S2025.46 via its fluorine atom[2]. [1]. Pingyuan Wang, et al. Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Recept... | |||
T36910 |
PF 04449913 maleate
|
||
Potent Smo antagonist (IC50 = 5 nM). Attenuates the leukemia-initiation potential of AML cells in a serial transplantation mouse model. Also eliminates self-propagation capacity of AML cells. Munchhof et al (2011) Discovery of PF-04449913, a potent and orally bioavailable inhibitor of smoothened. ACS Med.Chem.Lett. 3 106 PMID:24900436 |Fukushima et al (2016) Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cells. Cancer Sci. 107 1422 PMID:2... | |||
T36634 |
ZQ 16
|
||
Selective medium-chain free fatty acid receptor GPR84 agonist (EC50 = 139 nM). Exhibits no response at GPR40, GPR41, GPR119 or GPR120 at 100 μM. Activates calcium mobilization, inhibits cAMP accumulation, and induces ERK1/2 phosphorylation, receptor desensitization and internalization in vitro. Liu et al (2016) Design and synthesis of 2-alkylpyrimidine-4,6-diol and 6-alkylpyridine-2,4-diol as potent GPR84 agonists. ACS Med.Chem.Lett. 7 579 PMID:27326330 |Zhang et al (2016) Discovery and characte... | |||
T35488 |
(S)-PI3Kα-IN-4
(S)-PI3Kα-IN-4 |
||
(S)-PI3Kα-IN-4 is a potent inhibitor of PI3Kα, with an IC50 of 2.3 nM. (S)-PI3Kα-IN-4 shows 38.3-, 4.25-, and 4.93-fold selectivity for PI3Kα over PI3Kβ, PI3Kδ, and PI3Kγ, respectively. (S)-PI3Kα-IN-4 can be used for the research of cancer[1]. (S)-PI3Kα-IN-4 (compound 11) is a quinazolin-4(3H)-one derivative with 2-substituted-N-methylpropanamide substitution[1]. [1]. Dong J, et, al. Discovery of 3-Quinazolin-4(3 H)-on-3-yl-2, N-dimethylpropanamides as Orally Active and Selective PI3Kα Inhibitor... | |||
T36504 |
STY-BODIPY
STY-BODIPY,Styrene-BODIPY |
||
STY-BODIPY is a styrene-conjugated fluorogenic probe for radical-trapping antioxidant (RTA) activity.1 Co-autoxidation of the STY-BODIPY signal carrier and a hydrocarbon co-substrate can be quantified by monitoring the loss of absorbance at 571 nm. STY-BODIPY has been used to measure the activity of RTAs, as well as the kinetics and stoichiometry of RTA reactions in cell-free assays.1,2,3References1. Haidasz, E.A., Van Kessel, A.T.M., and Pratt, D.A. A continuous visible light spectrophotometric... | |||
T35817 |
Photoswitchable PAD Inhibitor (technical grade)
|
||
Photoswitchable PAD inhibitor is a photoactivated protein arginine deiminase (PAD) inhibitor and a derivative of BB-Cl-amidine that contains an azobenzene photoswitch allowing optical control of PAD activity.1 Without photoactivation, it is a weak inhibitor of PAD2 (IC50 = >100 μM) and is less potent than BB-Cl-amidine in inhibiting citrulline production in vitro (kinact/KIs = 2,300, 600, 1,000, and 10,510 M-1min-1 for PAD1-4, respectively) and does not inhibit histone H3 citrullination in HEK29... | |||
T38106 |
JC-171
|
||
JC-171 is a selective NLRP3 inflammasome inhibitor, with an IC50 of 8.45 μM for inhibiting LPS/ATP-induced interleukin-1β (IL-1β) release from J774A.1 macrophages[1]. JC-171 (0-100 μM) blocks NLRP3 inflammasome activation and IL-1β production in primary macrophages dose dependently[1]. ... | |||
T35638 |
SR 1903
|
||
SR 1903 is a modulator of retinoic acid receptor-related orphan receptor γ (RORγ) and liver X receptor (LXR).1 It is an inverse agonist of RORγ (IC50 = ~100 nM in a cell-based reporter assay) and an agonist of LXR. It also binds to peroxisome proliferator-activated receptor γ (PPARγ; IC50 = 209 nM) but does not activate it. SR 1903 (10 μM) inhibits LPS-induced expression of triggering receptor expressed on myeloid cells 1 (TREM-1) in RAW 264.7 cells. It also inhibits LPS-induced expression of th... | |||
T35527 |
PI3Kα-IN-4
PI3Kα-IN-4 |
||
PI3Kα-IN-4 is a potent, selective and orally active inhibitor of PI3Kα, with an IC50 of 1.8 nM. PI3Kα-IN-4 has antitumor activity[1]. PI3Kα-IN-4 (compound 10) inhibits PI3Kα, β, δ, and γ, with IC50s of 1.8, 271.0, 13.9, and 13.8 nM, respectively in kinase assays[1].PI3Kα-IN-4 inhibits PI3Kα, β, δ, and γ, with IC50s of 12.1,1393, 183, and >10000 nM, respectively in cell based assays[1]. PI3Kα-IN-4 (compound 10) (30 mg/kg; p.o. once daily for 21 d) achieves the best efficacy, which could inhibit t... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1284 |
Megestrol acetate
SC10363,醋酸甲地孕酮,BDH1298 |
Glucocorticoid Receptor; Estrogen/progestogen Receptor; Progesterone Receptor; HIV Protease; Autophagy | Autophagy; Endocrinology/Hormones; Microbiology/Virology; Others; Proteases/Proteasome |
Megestrol acetate (BDH1298) 是具有口服活性的合成孕激素。它还具有抗雄激素特性,可用于治疗厌食症和恶病质。 | |||
T13199 |
Triacsin C
WS 1228A,FR 900190 |
Others | Others |
Triacsin C, from Streptomyces aureofaciens, is a natural intracellular long-chain inhibitor of acyl-CoA synthetases (ACSL). | |||
T36950 |
Rubrofusarin triglucoside
|
||
Rubrofusarin triglucoside is a glycoside compound isolated from Cassia obtusifolia Linn seeds. Rubrofusarin triglucoside inhibits human monoamine oxidase A (hMAO-A) with an IC50 of 85.5 μM[1]. [1]. Pradeep Paudel, et al. Rubrofusarin as a Dual Protein Tyrosine Phosphate 1B and Human Monoamine Oxidase-A Inhibitor: An in Vitro and in Silico Study. ACS Omega. 2019 Jul 3;4(7):11621-11630. |